SoCal.Startups is building the most comprehensive resource for Southern California's tech scene.
SoCal.Startups
Be an early user
bioProtonics, Inc. logo

bioProtonics, Inc.

Santa Barbara, CA · Founded 2018
LAST FUNDING
$7.3M
Series A

BioProtonics is a pioneering company focused on advancing diagnostic imaging through its Magnetic Resonance Histopathology (MRH) technology. MRH offers a non-invasive, high-resolution method for analyzing tissue microarchitecture during routine MRI scans. MRH

Funding history

RoundAmount
Series A$7.3M
SEC Form D filed
Apr 9, 2026·Jul 25, 2025·Dec 31, 2024·Apr 10, 2024·Sep 20, 2023·Sep 12, 2023·Apr 21, 2023·Jan 18, 2023·Sep 15, 2022·Aug 10, 2021·Jul 1, 2021·Mar 19, 2021·Mar 25, 2020·Jan 9, 2020·Jul 25, 2019·Mar 7, 2019

About bioProtonics, Inc.

How much funding has bioProtonics, Inc. raised?

bioProtonics, Inc. has raised $7.3M in total funding. The most recent round was Series A.

Where is bioProtonics, Inc. headquartered?

bioProtonics, Inc. is headquartered in Santa Barbara, CA.

What does bioProtonics, Inc. do?

BioProtonics is a pioneering company focused on advancing diagnostic imaging through its Magnetic Resonance Histopathology (MRH) technology. MRH offers a non-invasive, high-resolution method for analyzing tissue microarchitecture during routine MRI scans. MRH

What problem does bioProtonics, Inc. solve?

Detecting early-stage disease and cancer typically requires costly, invasive surgical biopsies, and the site notes up to 40% false-negative rates with prostate biopsies.

What's bioProtonics, Inc.'s solution?

bioProtonics offers Magnetic Resonance Histopathology (MRH), a software-based MRI method that non-invasively measures micro-level tissue texture and pairs it with AI analysis to act as a 'digital biopsy,' aiming to replace or reduce reliance on surgical biopsies.

What makes bioProtonics, Inc. different?

The company cites a proprietary MRI pulse sequence targeting specific spatial wavelengths, full DICOM protocol compatibility for integration with existing imaging workflows, and adding as little as 90 seconds to a standard MRI scan.

What makes bioProtonics, Inc. notable?

bioProtonics appointed medical-device executive A. Burton Tripathi as CEO in June 2026 alongside a successful bridge financing round; PitchBook lists the U.S. National Science Foundation among its investors.

Leadership

DANIEL R. DOIRON
Executive Officer, Director
Executive Officer, Director
LinkedIn ↗
A. Burton Tripathi
Executive Officer, Director
TIMOTHY JAMES
Director
KRISTIN LOOMIS
Director
Ryan Shields
Director
Industry
B2B
Founded
2018
HQ
Santa Barbara, CA
Raised
$7.3M
Stage
Series A

Related terms

❝ Cite this page

Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated September 3, 2026.

MLA
"bioProtonics, Inc.: Funding & Investors." SoCal.Startups, September 3, 2026, https://socalstartups.io/companies/bioprotonics-inc. Accessed September 29, 2026.
APA
SoCal.Startups. (2026). bioProtonics, Inc.: Funding & Investors. Retrieved September 29, 2026, from https://socalstartups.io/companies/bioprotonics-inc
WIKIPEDIA (CITE WEB)
{{cite web |title=bioProtonics, Inc.: Funding & Investors |url=https://socalstartups.io/companies/bioprotonics-inc |website=SoCal.Startups |access-date=September 29, 2026}}
🏷 Embed this badge

Building or fundraising? Add this to your site to show you're listed on SoCal.Startups — the link back helps other founders and investors find you here too.

bioProtonics, Inc. featured on SoCal.Startups
HTML
<a href="https://socalstartups.io/companies/bioprotonics-inc" target="_blank" rel="noopener"><img src="https://socalstartups.io/badge.svg" width="220" height="52" alt="bioProtonics, Inc. featured on SoCal.Startups" /></a>
MARKDOWN
[![bioProtonics, Inc. featured on SoCal.Startups](https://socalstartups.io/badge.svg)](https://socalstartups.io/companies/bioprotonics-inc)